Antimicrobial peptides: a promising strategy for lung cancer drug discovery?
Farshid ZandsalimiSam TalaeiMehdi Noormohammad AhariShahin AghamiriPourya RaeeSoheil RoshanzamiriFatemeh YarianMojgan BandehpourZeinab Zohrab ZadehPublished in: Expert opinion on drug discovery (2020)
The combination of AMPs and other cancer treatment approaches such as chemotherapy, nanoparticle-based delivery systems, and photodynamic therapy can be used as a promising revolutionary strategy for the treatment of lung cancer. The most significant limitations of this strategy that need to be focused on are low efficiency and off-target events.